Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Calotropis gigantea is a large shrub native to South and Southeast Asia, commonly called the Crown flower or Giant milkweed. It is used extensively in traditional Indian medicine systems including Ayurveda, Unani, Siddha, and Chinese medicine. All parts of the plant, especially latex, root, bark, and leaves, possess pharmacological activities attributed to bioactive constituents like alkaloids, saponins, tannins, flavonoids, terpenoids, cardiac glycosides (e.g., calotropin), and quinones[2][3][5]. Proposed mechanisms include antioxidant, antibacterial, antifungal, analgesic, anti-inflammatory, cytotoxic, and wound healing effects[2][3][5]. Traditionally, it is used for conditions such as skin, digestive, respiratory, circulatory, and neurological disorders, as well as fever, leprosy, eczema, syphilis, elephantiasis, ulceration, cough, asthma, diarrhea, and joint pain[1][3][4][5][7][8]. Its extracts have shown cytotoxicity against some cancer cell lines in vitro[1]. The plant contains potent cardiac glycosides, which can be toxic in high doses, especially affecting heart function[8].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on calotropis gigantea.